BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Degasperi G, Cristea IA, Di Rosa E, Costa C, Gentili C. Parsing variability in borderline personality disorder: a meta-analysis of neuroimaging studies. Transl Psychiatry 2021;11:314. [PMID: 34031363 DOI: 10.1038/s41398-021-01446-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Spohrs J, Kuehnle V, Ferger MD, Abler B. Multimodaler Ansatz zum Verständnis des Zusammenspiels zwischen dem endokrinen und dem Endocannabinoidsystem, nicht suizidalem selbstverletzendem Verhalten und der Borderline-Persönlichkeitsstörung. Nervenheilkunde 2023;42:136-143. [DOI: 10.1055/a-1984-9925] [Reference Citation Analysis]
2 Leichsenring F, Heim N, Leweke F, Spitzer C, Steinert C, Kernberg OF. Borderline Personality Disorder: A Review. JAMA 2023;329:670-9. [PMID: 36853245 DOI: 10.1001/jama.2023.0589] [Reference Citation Analysis]
3 Yi X, Fu Y, Zhang Z, Jiang F, Xiao Q, Chen BT. Altered regional homogeneity and its association with cognitive function in adolescents with borderline personality disorder. J Psychiatry Neurosci 2023;48:E1-E10. [PMID: 36596589 DOI: 10.1503/jpn.220144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marceau EM, Ruocco AC, Grenyer BFS. Improving treatment outcomes for borderline personality disorder: what can we learn from biomarker studies of psychotherapy? Curr Opin Psychiatry 2023;36:67-74. [PMID: 36017562 DOI: 10.1097/YCO.0000000000000820] [Reference Citation Analysis]
5 Choi-kain LW, Sahin Z, Traynor J. Borderline Personality Disorder: Updates in a Postpandemic World. FOC 2022;20:337-352. [DOI: 10.1176/appi.focus.20220057] [Reference Citation Analysis]
6 Geurts DEM, Van den Heuvel TJ, Huys QJM, Verkes RJ, Cools R. Amygdala response predicts clinical symptom reduction in patients with borderline personality disorder: A pilot fMRI study. Front Behav Neurosci 2022;16:938403. [DOI: 10.3389/fnbeh.2022.938403] [Reference Citation Analysis]
7 Ho W, Kolla NJ. The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review. Behav Sci Law 2022. [PMID: 35575169 DOI: 10.1002/bsl.2576] [Reference Citation Analysis]
8 Chaudhary S, Zhornitsky S, Chao HH, van Dyck CH, Li CR. Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort. J Alzheimers Dis 2022;85:1251-65. [PMID: 34924392 DOI: 10.3233/JAD-215316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Steinmair D, Wong G, Frantal S, Rohm C, Löffler-Stastka H. Affect regulation in psychoanalytic treatments of patients with a borderline personality disorder-psychoanalysis and psychodynamic psychotherapy-a comparison. World J Psychiatry 2021;11:1328-45. [PMID: 35070781 DOI: 10.5498/wjp.v11.i12.1328] [Reference Citation Analysis]
10 Khodadadifar T, Soltaninejad Z, Ebneabbasi A, Eickhoff CR, Sorg C, Van Eimeren T, Vogeley K, Zarei M, Eickhoff SB, Tahmasian M. In search of convergent regional brain abnormality in cognitive emotion regulation: A transdiagnostic neuroimaging meta-analysis. Hum Brain Mapp 2021. [PMID: 34826162 DOI: 10.1002/hbm.25722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]